VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Anbio Biotechnology (NNNN) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medical Instruments & Supplies · market value about $157M · P/E 23.9 · revenue $8.6M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows